SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on lupus kidney damage in new trial
Disease control Not yet recruitingThis early-phase trial tests a new treatment called CRC01 for people with severe lupus that has damaged their kidneys. CRC01 is made from a patient's own immune cells, which are modified in a lab to target and calm the overactive immune system. The study will enroll 39 adults to …
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New drug ISH0613 takes first step: safety check in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug, ISH0613, in 26 healthy adults to see if it is safe and how the body processes it. Participants get one dose of the drug or a placebo and are closely monitored for side effects. This research is a first step before testing the drug in peopl…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC